Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Identification of Predictors of Tolerance to Chemoradiotherapy in Elderly Patients With Head and Neck Cancer
Authors not listed
UNC Lineberger Comprehensive Cancer Center · 2012
Abstract
To look at what types of measures can be used to predict how an older person will tolerate chemoradiation treatment for head and neck cancer. This study uses surveys and a blood draw to look at the different measures.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-30 MST
Cite this
APA
Anonymous. (2012). Identification of Predictors of Tolerance to Chemoradiotherapy in Elderly Patients With Head and Neck Cancer. <em>UNC Lineberger Comprehensive Cancer Center</em>. https://clinicaltrials.gov/study/NCT01688323
Vancouver
Anonymous. Identification of Predictors of Tolerance to Chemoradiotherapy in Elderly Patients With Head and Neck Cancer. UNC Lineberger Comprehensive Cancer Center. 2012.
BibTeX
@misc{anon2012Identi,
title = {Identification of Predictors of Tolerance to Chemoradiotherapy in Elderly Patients With Head and Neck Cancer},
author = {Anonymous},
journal = {UNC Lineberger Comprehensive Cancer Center},
year = {2012},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Reviews of Environmental Contamination and Toxicology 2023
Citation only
Cadmium, Cellular Senescence, and Cancer
Nature reviews. Cancer 2018
Preprint · OA
The molecular landscape of head and neck cancer
Doncaster And Bassetlaw Hospitals NHS Foundation Trust 2023
Open access · US-GOV
Assessing Frailty and Its Impacts in Older Patients Facing Major Gastrointestinal Surgery
University of California, Davis 2024
Open access · US-GOV
Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients
Clinical Research (Excluding Clinical Trials) 2019
Citation only
Abstract 1344: IL-6 blood level represents an independent biomarker of melanoma patient prognosis
Cancer Research 2019
Citation only